Chronic prostatitis

Current Opinion in Urology

Volumn 13, Issue 1, 2003, Pages 23-29

  Richard, G ^b   Batstone, D ^a,b   Doble, Andrew ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Chronic pelvic pain syndrome; Chronic prostatitis; Diagnosis; Epidemiology; Etiology; Treatment

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMITRIPTYLINE; ANALGESIC AGENT; CIPROFLOXACIN; FINASTERIDE; HERBACEOUS AGENT; PENTOSAN POLYSULFATE; QUERCETIN; RIBOSOME DNA; RNA 16S; ROFECOXIB; TAMSULOSIN;

AUTOIMMUNITY; BACTERIAL INFECTION; CELLULAR IMMUNITY; CHRONIC PROSTATITIS; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; MALE GENITAL TRACT INFECTION; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; SEXUALLY TRANSMITTED DISEASE; STRESS; SUN EXPOSURE; URINARY TRACT DISEASE;

ADULT; AGE DISTRIBUTION; AGED; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FINASTERIDE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PELVIC PAIN; PROGNOSIS; PROSTATITIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 12244292699     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200301000-00005     Document Type: Review

References (53)

1. Collins MM, Stafford RS, O'Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol 1998; 159:1224-1228.
2. Wenniger K, Heiman JR, Rothman I, et al. Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol 1996; 155:965-968.
3. McNaughton-Collins M, MacDonald R, Wilt TJ. Diagnosis and treatment of chronic abacterial prostatitis: a systematic review. Ann Intern Med 2000; 133:367-381.
4. Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968; 5:492-518.
5. Nickel JC. Prostatitis: evolving management strategies. Urol Clin North Am 1999; 26:737-751.
6. Ludwig M, Schroeder-Printzen I, Lüdecke G, Weidner W. Comparison of expressed prostatic secretions with urine after prostatic massage a means to diagnose chronic prostatitis/inflammatory chronic pelvic pain syndrome. Urology 2000; 55:175-177.
7. World Health Organization, Laboratory manual for the examination of human semen and sperm-cervical mucus interaction, 4th ed. 1999; 61.
8. Nickel JC, Downey J, Johnston B, et al. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol 2001; 165:1539-1544. This study demonstrated the equal benefit of antibiotics in all categories of CPPS, seriously questioning the relevance of "bacterial prostatitis" as determined by the Stamey localization in men who present with symptoms of pelvic pain.
9. Nickel JC, Alexander RB, Schaeffer AJ, et al. Leukocyte and bacteria localization comparisons in men with chronic pelvic pain syndrome and asymptomatic men: a case controlled study [abstract]. J Urol 2002; 165 (Suppl.):24. This study shows that an equal number of normal men and men with symptoms of pelvic pain have bacteria "localized" to the prostate on the Stamey localization. This research, when published, will probably be the end of the Stamey localization procedure.
10. O'Shaughnessy EJ, Parrino PS, White JD. Chronic prostatitis - fact or fiction? JAMA 1956; 160:540-542.
11. Wright ET, Chmiel JS, Grayhack JT, Schaeffer AJ. Prostatic fluid inflammation in prostatitis. J Urol 1994; 152:2300-2303.
12. Muller CH, Berger RE, Mohr LE, Krieger JN. Comparison of microscopic methods for detecting inflammation in expressed prostatic secretions. J Urol 2001; 166:2518-2524. This paper demonstrates that the haemocytometer is the "gold standard" for evaluating the presence of leukocytes in EPS.
13. Nickel JC, True LD, Krieger JN, et al. Consensus development of a histopathological classification system for chronic prostatic inflammation. Br J Urol Int 2001; 87:787-805. This article outlined the accepted classification for the determination of histological inflammation, which should be adopted for all further studies of histological prostatitis - to allow for standardized comparisons between studies.
14. McNaughton-Collins M, Meigs JB, Barry MJ, et al. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol 2002; 167:1363-1366. This is the largest epidemiological study of prostatitis to date, and shows important correlates of prostatitis. Importantly, it shows the association of BPH and lower urinary tract symptoms with prostatitis, which may mean that upon the resolution of "prostatitis" the disturbance of urination is diagnosed as BPH or lower urinary tract symptoms.
15. Berger RE, Krieger JN, Kessler D, et al. Case control study of men with suspected chronic idiopathic prostatitis. J Urol 1989; 141:328-331.
16. Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index. J Urol 2001; 165:842-845. This study uses the NIH-CPSI for the first time in an epidemiological study.
17. Litwin MS, McNaughton-Collins M, Fowler FJ, et al. The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. J Urol 1999; 162:369-375.
18. Ku JH, Kim ME, Lee NK, Park YH. Influence of environmental factors on chronic prostatitis-like symptoms in young men: results of a community based survey. Urology 2001; 58:853-858. This study points to diminished sunlight exposure and reduced educational levels as being associations of "prostatitis-like" symptoms.
19. Roberts RO, Lieber MM, Rhodes T, et al. Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology 1998; 51:578-584.
20. Mehik A, Hellström P, Lukkarinen O, et al. Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. Br J Urol Int 2000; 86:443-448.
21. Mehik A, Hellström P, Sarpola A, et al. Fears, sexual disturbance and personality features in men with prostatitis: a population-based cross-sectional study in Finland. Br J Urol Int 2001; 88:35-38. This study shows that clinicians need to allay the fears of prostate cancer in treating men with prostatitis.
22. Dennis LK, Lynch CF, Torner JC. Epidemiologic association between prostatitis and prostate cancer. Urology 2002; 60:78-83.
23. Turner JA, Hauge S, Von Korff M, et al. Primary care and urology patients with the male pelvic pain syndrome: symptoms and quality of life. J Urol 2002; 167:1768-1773. Demonstrates that not air "prostatitis" patient populations are equal in terms of the duration or severity of symptoms.
24. McNaughton-Collins M, Pontari MA, O'Leary MP, et al. Quality of life is impaired in men with chronic prostatitis. J Gen Intern Med 2001; 16:656-662. Uses a validated quality of life assessment measure to determine the impact of chronic prostatitis on patients presenting to tertiary referral centres in north America. This is not necessarily a representative patient population group for the average urologist.
25. Miller LJ, Fischer KA, Goralnick SJ, et al. Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. J Urol 2002; 167-753-756. A case-controlled study, which shows the elevation of seminal plasma cytokines in CPPS, along with the correlation of urinary symptoms and seminal plasma cytokines.
26. Miller LJ, Fischer KA, Goralnick SJ, et al. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology 2002; 59:603-608.
27. Orhan I, Onur R, Ilhan N, Ardiçoglu A. Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome. Int J Urol 2001; 8:495-499. A case-controlled study, which shows the elevation of seminal plasma cytokines in CPPS.
28. John H, Barghorn A, Funke G, et al. Noninflammatory chronic pelvic pain syndrome: immunological study in blood, ejaculate and prostate tissue. Eur Urol 2001; 39:72-78. This study of IIIB prostatitis shows that "non-inflammatory" prostatitis is not necessarily non-inflammatory. It also strongly points to an autoimmune process with the involvement of CD8 T cells. A strong correlation of seminal plasma cytokines and histological inflammation was also demonstrated.
29. Alexander RB, Ponniah S, Hasday J, Hebel JR. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology 1998; 52:744-749.
30. Nadler RB, Koch AE, Calhoun EA, et al. IL-1 beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol 2000; 164:214-218.
31. Hochreiter WW, Nadler RB, Koch AE, et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology 2000; 56:1025-1029.
32. 2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response. J Urol 2001; 166:1738-1741.
33. Quayle AJ, Kelly RW, Hargreaves TB, James K. Immunosuppression by seminal seminal prostaglandins. Clin Exp Immunol 1989; 75:387-391.
34. Nelson G, Culberson DE, Gardner WA. Intraprostatic spermatozoa. Hum Pathol 1988; 19:541-544.
35. Shoskes DA, Albakri Q, Thomas K, Cook D. Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: associations with diagnosis and treatment responses. J Urol 2002; 168:331-335. Shows that some CPPS patients have the genotype of low IL-10 producers (IL-10 is a regulatory, "anti-inflammatory" cytokine), again points to auto-immunity.
36. Mehik A, Hellström P, Nickel JC et al. The chronic prostatitis-chronic pelvic pain syndrome can be characterized by prostatic tissue pressure measurements. J Urol 2002; 167:137-140. Demonstrates elevated prostatic tissue pressures in CPPS; ejaculation was not controlled for, which may be important.
37. Ludwig M, Stelz C, Huwe P, et al. Immunological analysis of leukocyte subpopulations in urine specimens before and after prostatic massage. Eur Urol 2001; 39:277-282. A study that shows the involvement of adaptive and innate immunity in CPPS, in the absence of detectable infection, and again points to autoimmunity.
38. Doble A. Textbook of prostatitis. Nickel JC, editor. Oxford: ISIS; 1999. pp. 134-135.
39. Batstone GRD, Doble A, Gaston JSH. Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS). Clin Exp Immunol 2002; 128:302-307. Using the highly immune inhibitory seminal plasma as an antigen source, this group demonstrates that patients' peripheral T cells proliferate to the seminal plasma. It strongly points to an autoimmune cause of CPPS, which is mediated by a T cell response to an antigen found in the seminal plasma. The determination of the seminal plasma antigen should improve our understanding of the pathogenesis of CPPS.
40. Alexander RB, Brady F, Ponniah S. Autoimmune prostatitis. Evidence of T cell reactivity with normal prostatic proteins. Urology 1997; 50:893-899.
41. Krieger JN, Riley DE. Bacteria in the chronic prostatitis-chronic pelvic pain syndrome: molecular approaches to critical research questions. J Urol 2002; 167:2574-2583. An excellent review that summarizes the work of this group using the polymerase chain reaction to identify bacteria in the prostate of men with CPPS. It demonstrates the techniques that this group will use to determine whether bacteria are viable or not.
42. Krieger JN, Riley DE. Prostatitis: what is the role of infection. Int J Antimicrob Agents 2002; 19:475-476.
43. Doble A, Walker MM, Harris JR, et al. Intraprostatic antibody deposition in chronic abacterial prostatitis. Br J Urol 1990; 65:598-605.
44. True LD, Berger RE, Rothman I, et al. Prostate histopathology and chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study. J Urol 1999; 162:2014-2018.
45. Kwon SM, Kim SI, Chun DC, et al. Development of rat prostatitis model by oral administration of isoflavone and its characteristics. Yonsei Med J 2001; 42:395-404. A new animal model, which demonstrates prostate zone specific inflammation, may be an important consideration for human biopsy studies.
46. Keith IM, Jin J, Neal D Jr, et al. Cell relationship in a Wistar rat model of spontaneous prostatitis. J Urol 2001; 166:323-328.
47. Kunishima Y, Matsukawa M, Takahashi S, et al. National Institutes of Health Chronic Prostatitis Symptom Index for Japanese men. Urology 2002; 60:74-77.
48. McNaughton-Collins M, O'Leary MP, Calhoun EA, et al. The Spanish National Institutes of Health - Chronic Prostatitis Symptom Index: translation and linguistic validation. J Urol 2001; 166:1800-1803.
49. Ikonen S, Kivisaari L, Tervahartiala P, et al. Prostatic MR imaging, accuracy in detecting cancer from other prostatic disorders. Acta Radiol 2001; 42:348-354.
50. Narayan P, McKay J, Doyle C. A six-week double-blind pilot study of tamsulosin versus placebo in patients with chronic non-bacterial prostatitis/chronic pelvic pain [abstract]. J Urol 2002; 167 (Suppl.):24.
51. Downey J, Nickel JC, Pontari MA, et al. Randomized placebo controlled multi-center pilot study to evaluate the safety and efficacy of finasteride in the treatment of male chronic pelvic pain syndrome: category IIIa CPPS (chronic nonbacterial prostatitis) [abstract]. J Urol 2002; 167 (Suppl.):26.
52. Nickel JC, Gittleman M, Malek G, et al. Effects of Rofecoxib in patients with chronic nonbacterial prostatitis: a placebo controlled pilot study [abstract]. J Urol 2001; 165 (Suppl. 5):27.
53. Propert KJ, Alexander RB, Nickel JC, et al. Design of a multi-center randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology 2002; 59:870-876.